The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole

M Robert, M Salva, R Segarra, M Pavesi, R Esbri… - Drug Metabolism and …, 2007 - ASPET
The present clinical trial was designed to evaluate the possible pharmacokinetic and
electrocardiographic interactions of the gastroenteric prokinetic drug cinitapride with ketoconazole. …

Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis

P Ratner, M Falqués, F Chuecos, R Esbrí… - International archives of …, 2005 - karger.com
Background: Few randomized studies have compared the efficacy of ebastine and
loratadine in the symptomatic treatment of seasonal allergic rhinitis (SAR). Methods: A meta-analysis …

Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges

…, M Barbanoj, I Gich, E Garcia, R Esbrí… - Annals of Allergy …, 2002 - Elsevier
BACKGROUND: Few studies have compared the antihistaminic effect of ebastine at 20 mg/day
(maximal recommended daily dose) with the effect found for other antihistamines in …

Long‐term efficacy and safety of oral almotriptan: Interim analysis of a 1‐year open study

X Cabarrocas, R Esbri, F Peris… - Headache: The Journal …, 2001 - Wiley Online Library
Objective.—To assess the long‐term tolerability and safety of a single, oral 12.5‐mg dose of
almotriptan and its efficacy in alleviating pain associated with consecutive migraine …

Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind …

…, C García-Gea, M Puntes, J Pérez, R Esbrí… - Clinical …, 2007 - Elsevier
BACKGROUND:: Ebastine is a long-acting, second-generation, selective histamine H1-receptor
antagonist. A fast-dissolving tablet formulation of ebastine has been developed at 10- …

A comparison of ebastine 10mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults

…, C García-Gea, M Puntes, M Valle, R Esbri… - Clinical drug …, 2007 - Springer
Background and objective: Ebastine is a long-acting, second-generation selective histamine
H 1 receptor antagonist. The pharmacodynamics of a new 10mg fast-dissolving tablet (FDT) …

[HTML][HTML] Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial1, 2

E Batlle-Gualda, JR Ivorra, E Martin-Mola… - Osteoarthritis and …, 2007 - Elsevier
OBJECTIVE: To evaluate the efficacy and tolerability of aceclofenac, 200mg/day, and
paracetamol, 3000mg/day, in the treatment of osteoarthritis (OA) of the knee. METHODS: This was …

[HTML][HTML] Effect of a multicomponent exercise program and cognitive stimulation (VIVIFRAIL-COGN) on falls in frail community older persons with high risk of falls: study …

…, D Moral-Cuesta, I Marín-Epelde, F Ramon-Espinoza… - BMC geriatrics, 2022 - Springer
Background Falls represent important drivers of intrinsic capacity losses, functional limitations
and reduced quality of life in the growing older adult’s population, especially among those …

[PDF][PDF] STUDY PROTOCOL

…, I Marín‑Epelde, F Ramon‑Espinoza… - 2022 - bmcgeriatr.biomedcentral.com
Background: Falls represent important drivers of intrinsic capacity losses, functional limitations
and reduced quality of life in the growing older adult’s population, especially among those …

Correction: Effect of a multicomponent exercise program and cognitive stimulation (VIVIFRAIL-COGN) on falls in frail community older persons with high risk of falls …

…, I Marín-Epelde, F Ramon-Espinoza… - BMC …, 2023 - ncbi.nlm.nih.gov
After publication of this article [1], the authors reported that the statement in the Funding
information section was incorrectly given as’ The present study is funded by a grant from the …